Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00356382 · ClinicalTrials.gov registry record · Phase 3
Decreasing Rates of Illness in Kids (DRINK)
A Phase 3 study, sponsored by Georgetown University.
- Completed
- Registry status
- Phase 3
- Development phase
- 638
- Enrollment target
NCT00356382 is a Phase 3 study that has completed, run by Georgetown University. The registered enrollment target is 638 participants.
The verdict
NCT00356382, a Phase 3 study, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 638 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness of a cultured dairy drink with high concentrations of active L casei to reduce the cumulative rate of illness in daycare/school children ages 3 to 6.
Interventions
- DRUG Lactobacillus (L.) casei
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 638 participants |
| Start Date | 2006-09 |
| Est. Completion | 2007-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00356382
The ClinicalTrials.gov registry entry for NCT00356382 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 638 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lactobacillus (L.) casei is the first listed.
NCT00356382 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00356382 about?
NCT00356382 is a clinical study titled "Decreasing Rates of Illness in Kids (DRINK)". The purpose of this study is to determine the effectiveness of a cultured dairy drink with high concentrations of active L casei to reduce the cumulative rate of illness in daycare/school children ages 3 to 6.
What is the current status of trial NCT00356382?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 638 participants. The study started on 2006-09. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00356382?
The interventions under investigation include: Lactobacillus (L.) casei (DRUG).
Who is sponsoring clinical trial NCT00356382?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.